High risk of subclinical atherosclerosis in COPD exacerbator phenotype.
Domenech A, Muñoz-Montiel A, García-Casares N, Rioja J, Ruiz-Esteban P, Gutierrez-Castaño P, Prunera Pardell MJ, Olveira C, Valdivielso P, Sánchez-Chaparro MÁ.
Domenech A, et al.
Respir Med. 2018 Aug;141:165-171. doi: 10.1016/j.rmed.2018.07.004. Epub 2018 Jul 17.
Respir Med. 2018.
PMID: 30053963
Free article.